Burkitt's lymphoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Burkitt's lymphoma}} | {{Burkitt's lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement. | |||
==Staging== | |||
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement. | |||
Staging for Burkitt's lymphoma is provided in the following table: | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
|+ '''Murphy staging system''' | |||
! style="background: #4479BA; color:#FFF;" | Stage | |||
! style="background: #4479BA; color:#FFF;" | Involvement | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Single nodal or extra nodal site excluding mediastinum or abdomen | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Single extra nodal tumor with regional nodal involvement | |||
* Two extra nodal tumors on one side of diaphragm | |||
* Primary gastrointestinal tumor with or without associated mesenteric nodes | |||
* Two or more nodal areas on one side of diaphragm | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IIR | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Completely resected intra-abdominal disease | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage III | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* Two single extra nodal tumors on opposite sides of diaphragm | |||
* All primary intra thoracic tumors | |||
* All paraspinal or epidural tumors | |||
* All extensive primary intra-abdominal disease | |||
* Two or more nodal areas on opposite sides of diaphragm | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IIIA | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Localized, non-resectable abdominal disease | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IIIB | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Widespread multi organ abdominal disease | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IV | |||
| style="padding: 5px 5px; background: #F5F5F5;" | Initial CNS or bone marrow involvement (< 25%) | |||
|} | |||
==References== | ==References== | ||
{{ | {{reflist|2}} | ||
{{Hematology}} | |||
{{Hematological malignancy histology}} | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category: | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 20:02, 30 September 2015
Burkitt's lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Burkitt's lymphoma staging On the Web |
American Roentgen Ray Society Images of Burkitt's lymphoma staging |
Risk calculators and risk factors for Burkitt's lymphoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement.
Staging
According to the Murphy staging system, there are four stages of Burkitt's lymphoma based on the number of nodes and extra nodal involvement. Staging for Burkitt's lymphoma is provided in the following table:
Stage | Involvement |
---|---|
Stage I | Single nodal or extra nodal site excluding mediastinum or abdomen |
Stage II |
|
Stage IIR | Completely resected intra-abdominal disease |
Stage III |
|
Stage IIIA | Localized, non-resectable abdominal disease |
Stage IIIB | Widespread multi organ abdominal disease |
Stage IV | Initial CNS or bone marrow involvement (< 25%) |